resveratrol has been researched along with palbociclib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, TC; Delgado, M; Kacprzak, K; Urbaniak, A | 1 |
1 other study(ies) available for resveratrol and palbociclib
| Article | Year |
|---|---|
Activity of resveratrol triesters against primary acute lymphoblastic leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esters; G1 Phase Cell Cycle Checkpoints; Humans; Molecular Structure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes; Structure-Activity Relationship | 2017 |